Plain-English translation of NCT07902622 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers in Pakistan are building a registry—essentially a detailed database—of lupus patients to learn more about how the disease affects people in their community. By collecting information about your symptoms, disease severity, and how well different treatments work for you, the study aims to improve how doctors manage lupus and develop better care guidelines.
Lupus is a complex disease that affects different people in different ways, and doctors need more real-world information to understand which treatments are most effective and how to prevent serious complications. This registry will help fill gaps in knowledge about lupus in Pakistan and contribute to better care practices across the region.
You likely qualify if…
You likely don't qualify if…
You will be asked to share your medical records, including information about your lupus symptoms, disease activity, and past and current treatments. Researchers will follow your care over time through visits to the clinic, tracking how your disease progresses and how well your treatments are working. The study will eventually include patients from multiple hospitals across Pakistan, starting with 150–200 patients in the first year.
AI-generated summary from trial data · Nov 1, 2026 · Not medical advice
Pakistan
Foundation University Islamabad
Collaborators
Fauji Foundation Hospital
Enrollment target
~3,000 participants
Started
March 2025
Primary completion
May 2036
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dr. Shahida Perveen, FCPS, Rheumatology
Foundation University Islamabad
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.